Online Database of Chemicals from Around the World Search | Submit | Advertise

Home >> Chemical Listing >> Cemdisiran>> Market Analysis Reports
 

Market Analysis Reports of Cemdisiran

Complement C5 inhibitors - Pipeline Insight, 2022
... Zilucoplan ISU 305 SB12 5G1-1 Cemdisiran Avacincaptad pegol

Atypical Hemolytic Uremic Syndrome (Nondiarrhea - Associated Hemolytic Uremic Syndrome) - Pipeline Review, H2 2018
Atypical Hemolytic Uremic Syndrome (Nondiarrhea - Associated Hemolytic Uremic Syndrome) - Pipeline Review, H2 2018 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Atypical Hemolytic Uremic Syndrome - Pipeline ...

Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) - Pipeline Review, H2 2018
Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) - Pipeline Review, H2 2018 SUMMARY Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) pipeline Target constitutes close to 33 ...

Paroxysmal nocturnal haemoglobinuria - Pipeline Insight, 2021
... Pegcetacoplan (APL-2) Pozelimab Nomacopan Crovalimab Cemdisiran BCX-9930 KP-104 MASP-2 therapeutics ...

Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) - Pipeline Review, H1 2018
Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) - Pipeline Review, H1 2018 SUMMARY Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) pipeline Target constitutes close to 32 ...

Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain ...




Copyright ©  chemBlink. All rights reserved. Content Disclaimer | about chemBlink | Contact